WCPO: Despite bribery charges, city will pay $152K in salaries and benefits
UC political scientist David Niven comments on city councilmembers suspension with pay
Cincinnati City Council member Jeff Pastor and PG SittenfeldI will continue to get paid, although suspended while awaiting trial for corruption charges.
State law allows them to collect full salaries until their cases are resolved in court or their council terms expire on Jan. 3, 2022.
“It is a lot of money,” says David Niven, an associate professor in UC’s Department of Political Science; and paying suspended members, he says, is a financial burden on Cincinnati when they are "two extra council members who literally can’t do anything.”
Niven teaches American politics and conducts research on campaigns, political communication and death penalty policy.
Featured image at top of Cincinnati skyline: Unsplash.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
WLWT: Tips to fight off bad allergy symptoms
April 18, 2024
The University of Cincinnati's Ahmad Sedaghat spoke with WLWT about how Cincinnati's geography tends to make allergy symptoms worse and tips to fight off those symptoms.
UC’s Ground Floor Makerspace births combat robots
April 17, 2024
In the heart of UC's 1819 Innovation Hub lies the Ground Floor Makerspace, an advanced and active hub of ingenuity where students, faculty and the community converge to bring their ideas to life. This includes being the birthplace of robots much like miniature race cars, combating fender to fender in an enclosed boxing ring. Combat robots like UC's Maximizer will again be fighting for first place in the National Havoc Robot League (NHRL) competition, slated for April 20.
Medscape: Skin adverse events rare after immunotherapy to treat...
April 17, 2024
Medscape highlighted University of Cincinnati research published in JAMA Dermatology that found skin adverse events were rare following immunotherapy treatments for certain skin cancers.